The Finnish Medicines Verification Organisation FiMVO (Suomen Lääkevarmennus Oy) is responsible for the setting up and managing the Medicines Verification System in Finland. In accordance with EU legislation, we are a non-profit company.
The company was founded in December 2016. The founders of FiMVO are Pharma Industry Finland, Orion Corporation, the Finnish Generic Pharmaceutical Association, Suppliers of Parallel Imported Medicines in Finland, the Association of Finnish Pharmacies and the Association of Pharmaceutical Distributors.
Hospital pharmacies are also represented in the Steering Group for the ramp-up of the system. In general, the entire Finnish medicines supply chain is heavily involved in building the verification system.
Our mission is to ensure that the system is up and running in November 2018. EU legislation requires the system to be operational by 9.2.2019 at the latest. We are responsible for ensuring that the system operates in accordance with the legislation and that all actors in the supply have the opportunity to join the system.
On a European level, the central repository i.e. the EU Hub is managed by the European Medicines Verification Organization (EMVO). Its members are the European pharmaceutical industry, pharmaceutical wholesalers, pharmacies and hospital pharmacies associations. More information is available here.
Medicines purchased from the legal supply chain are safe
The Medicines Verification System protects patients from falsified medicines.
Falsifications are a significant threat to medicines users. They can be found in both the legal supply chain and outside of it. In the Finnish legal supply chain falsifications have been found twice.
Falsified medicines may include wrong, ineffective or even dangerous ingredients. When ordering medicines from an unlawful source such as an illegal online shop, there is a serious risk to personal health. This is why it's important to buy medicines from a safe source, a Finnish pharmacy (online or in person).
EU Commission's falsified medicines site.